Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results

Keywords

Hematology ×

Classification ×

Table of contents

Select data models

Selected data models

You must log in to select data models for download or further analysis.

6 Search results.

Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593 - Central Pathology Assessment and Description

- 9/20/21 - 1 form, 7 itemgroups, 21 items, 1 language

Itemgroups: Biopsy,Biopsy ,Lymphoma, Non-Hodgkin | Classification,Pathologist evaluation | Central,Basis of Assessment,Pathologist evaluation | Central | Description,Administrative

Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

MDS Score Nordic Score

- 8/28/16 - 1 form, 2 itemgroups, 3 items, 1 language

Itemgroups: Score: Items,Score: Result

MDS Score Nordic Score Hellstrom-Lindberg E, Negrin R, Stein R, Krantz S, Lindberg G, Vardiman J, Ost A, Greenberg P. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. British journal of haematology. 1997;99(2):344-51. PMID: 9375752.

MDS Score CMML-Specific Prognostic Scoring System

- 8/28/16 - 1 form, 2 itemgroups, 6 items, 1 language

Itemgroups: Score: Items,Score: Result

MDS Score CMML-Specific Prognostic Scoring System Such E, Germing U, Malcovati L, Cervera J, Kuendgen A, Della Porta MG, Nomdedeu B, Arenillas L, Luno E, Xicoy B, Amigo ML, Valcarcel D, Nachtkamp K, Ambaglio I, Hildebrandt B, Lorenzo I, Cazzola M, Sanz G. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013;121(15):3005-15. PMID: 23372164. doi: 10.1182/blood-2012-08-452938.

MDS Score WHO classification-based prognostic scoring system

- 8/28/16 - 1 form, 2 itemgroups, 5 items, 1 language

Itemgroups: Score: Items,Score: Result

MDS Score WHO classification-based prognostic scoring system Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25(23):3503-10. PMID: 17687155. doi: 10.1200/JCO.2006.08.5696.

MDS Score International Prognostic Scoring System

- 8/17/16 - 1 form, 2 itemgroups, 6 items, 1 language

Itemgroups: Score: Items,Score: Result

MDS Score International Prognostic Scoring System http://www.kompetenznetz-leukaemie.de/content/aerzte/mds/scores/ipss/ Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079-88. PMID: 9058730. Germing U, Hildebrandt B, Pfeilstocker M, Nosslinger T, Valent P, Fonatsch C, Lubbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis AA, Strupp C, Kundgen A, Mueller T, Haas R, Gattermann N, Aul C. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Leukemia. 2005;19(12):2223-31. PMID: 16193087. doi: 10.1038/sj.leu.2403963.

MDS Score IPSS-R

- 8/17/16 - 1 form, 2 itemgroups, 7 items, 1 language

Itemgroups: Score: Items,Score: Result

MDS Score IPSS-R Greenberg PL,Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012;120(12):2454-65. PMID: 22740453. doi: 10.1182/blood-2012-03-420489.

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.